The use of activated recombinant coagulation factor VII during haemarthroses and synovectomy in a patient with congenital severe factor V deficiency

Haemophilia

Volumn 11, Issue 2, 2005, Pages 167-170

  González Boullosa, Rosario ^a   Ocampo Martinez R ^a   Alarcon Martin M J ^a   Suarez Rodriguez M ^a   Dominguez Viguera L ^a   Gonzalez Fajo G ^a  

^a HOSPITAL XERAL CÍES   (Spain)

Author keywords

Factor V deficiency; Haemarthrosis; NovoSeven; Recombinant FVIIa; Synovectomy

Indexed keywords

ANTIHISTAMINIC AGENT; BLOOD CLOTTING FACTOR 5; CORTICOSTEROID; DIURETIC AGENT; FRESH FROZEN PLASMA; HEMOSTATIC AGENT; HLA ANTIBODY; HLA ANTIGEN CLASS 1; MORPHINE; OXYGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ACUTE DISEASE; ADULT; ALLERGIC REACTION; ARTHRALGIA; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD TRANSFUSION REACTION; BONE EROSION; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSPNEA; ERYTHROCYTE TRANSFUSION; FEMALE; HEMARTHROSIS; HEMATOMA; HUMAN; HYPOXEMIA; JOINT MOBILITY; JOINT RADIOGRAPHY; LUNG EDEMA; MENORRHAGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL BLEEDING; PHYSIOTHERAPY; PLASMA TRANSFUSION; PRIORITY JOURNAL; PRURITUS; SHOULDER; SUBLUXATION; SYNOVECTOMY; SYNOVITIS; THORAX RADIOGRAPHY; THROMBOEMBOLISM; URTICARIA;

BLOOD COAGULATION FACTORS; FACTOR V DEFICIENCY; FACTOR VII; FEMALE; HEMARTHROSIS; HEMATOMA; HEMOSTASIS; HUMANS; MIDDLE AGED; PHYSICAL THERAPY MODALITIES; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; SHOULDER JOINT; SYNOVIAL MEMBRANE; TREATMENT OUTCOME;

EID: 16344365612     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2005.00956.x     Document Type: Article

References (6)

1. Seligsohn U, Gilbert C. White I. Inherited - deficiencies of coagulation factors II, V, VII, XI, and XIII and the combined deficiencies of factors V and VIII and of the vitamin K-dependent factors. In: Beutler E, Lichtman MA, Coller BS et al., eds. Williams Hematology, 6th edn. London: McGraw-Hill, 2001: 1617-38.
2. Borel-Derlon A, Slaoui M, Le Querrec A, Hugel B, Vos HL. Severe congenital factor V deficiency: successful treatment with recombinant factor VIIa in two brothers. Blood 2002; 100 (abstract no. 3876).
3. Divanon F, Hecquard C, Borel-Derlon A. Experience with use of recombinant activated factor VII. J Clin Pharm Ther 2002; 27: 133-8.
4. Altisent C, Lozano M, Sol E et al. Dental extraction using rFVIIa in a patient with severe FV deficiency. Haemophilia 2000; 6: 408.
5. Pruss A, Kalus U, Radtke H et al. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Transfus Apheres Sci 2004; 30: 41-6.
6. Silliman CC, Boshkov LK, Mehdizadehkashi Z et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454-62.